REGENERON PHARMACEUTICALS, INC. (REGN) Gross profit 2016–2020
REGENERON PHARMACEUTICALS, INC. (REGN) annual gross profit history from SEC filings — each fiscal year as reported.
$8.1BFY2020 · since FY2016: $4.6B → $8.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $8.1B | +28.1% |
| FY2019 | $6.3B | +27.9% |
| FY2018 | $4.9B | -12.9% |
| FY2017 | $5.7B | +22.9% |
| FY2016 | $4.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice